Global Experts to Convene in Utrecht for Cancer Immunotherapy Breakthroughs
Utrecht, Monday, 5 May 2025.
The International Cancer Immunotherapy Conference (CICON25) will gather over 1,000 experts in Utrecht, illustrating advancements in immuno-oncology and fostering collaborative innovation from September 10-12, 2025.
Leading Global Forum for Immuno-Oncology
The conference, co-presented by the Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI), represents a significant milestone in cancer research. As a leading global forum for translational immuno-oncology research, CICON25 continues the tradition of alternating between the United States and Europe since 2015 [1]. The Netherlands was specifically selected by ENCI as the host country, owing to its robust research and innovation economy that makes it an ideal venue for bringing together scientific leaders, clinicians, and industry partners [1].
Comprehensive Research Program
The conference will feature an extensive program including plenary lectures, roundtable discussions, and poster sessions. Abstract submissions are currently being accepted through June 1, 2025, across five crucial categories: New Targets and Lead Structures, Tumor Microenvironment and Immunosuppression, Computational Immunology, Cellular Therapies, and Biomarker Strategies [1]. This comprehensive approach ensures coverage of the most pressing areas in cancer immunotherapy research. Authors of particularly noteworthy abstracts will have the opportunity to present their findings through short talks, fostering direct engagement with the international research community [1].
Industry Engagement and Innovation
CICON25 will serve as a crucial platform for institutes and companies to showcase their latest technologies, services, and organizational cultures [1]. The conference organizers are actively encouraging industry participation through sponsorship opportunities and exhibition spaces, facilitating direct interaction between researchers and commercial partners. This collaborative environment aims to accelerate the translation of scientific discoveries into practical therapeutic applications [1].